Patient Forum: CAR T-Cell Therapy & Scleroderma - Today and Future (2024)

These sessions will explore the historical work on immunological reset for treatment resistance, B cell depletion therapy alongside CAR T therapy, the use of natural killer cells engineered to target CD19, and precision immunotherapies.
Presented by Peter Merkel, MD (Professor of Medicine and Epidemiology and Chief of the Division of Rheumatology, University of Pennsylvania School of Medicine) Max Konig, MD (Assistant Professor of Medicine, Johns Hopkins University of Medicine) Peter Maag, PhD (Chief Executive Officer, Kyverna), and David Shook, MD (Chief Medical Officer, Nkarta).
This session was originally presented on June 3, 2024, as part of the 3rd annual SRF Patient Forum, “Collaborating for a Cure.”
Learn more at www.srfcure.org